Gene Therapy Market is likely to witness an impressive CAGR of 27.8% during the forecast period. The prime factors contributing to the growth of the market are rising incidences of cancer, and other chronic diseases, availability of reimbursements, and increasing approvals and launches of new products.

1. www.stratviewresearch.com Market Reports Advisory & Consulting Sourcing Intelligence
Gene Therapy Market
The Gene Therapy Market is Segmented by Vector Type (Non-Viral Vectors, Viral Vectors ), by Indication
Type (Neurological Diseases, Cancer, Hepatological Diseases, Duchenne Muscular Dystrophy, and Others),
by Delivery Method Type (In Vivo Gene Therapy, Ex Vivo Gene Therapy), and by Region (North America,
Europe, Asia-Pacific, and Rest of the World).
sales@stratviewresearch.com
+1-313-307-4176
Presents a Research Report on

2. www.stratviewresearch.com
Gene Therapy Market: Growth and Forecast Highlights & Drivers
2
• Gene Therapy Market is likely to witness an impressive CAGR of 27.8% during the forecast period.
• The prime factors contributing to the growth of the market are rising incidences of cancer, and other chronic diseases,
availability of reimbursements, and increasing approvals and launches of new products.
• Gene therapy is a technique which uses the introduction of DNA into a patient’s body in order to treat or prevent a
disease.
• A functioning gene is present in the introduced DNA, to correct the effects of a disease, which causes mutations.
• This therapy aims at reestablishing normal function and involves repairing, repressing, or replacing dysfunctional
genes that cause disease.
• Gene therapy:
• Serves as a promising treatment option for some genetic diseases such as muscular dystrophy and cystic
fibrosis, certain inherited disorders, cancer, and viral infections.
• Addresses the root cause of severe diseases by aiding in drug development to identify the right target and
approach.
• Provides a path to produce the functional protein in case of certain disorders where known genetic mutations
lead to deficient or nonfunctional protein production by fixing the underlying defect.
• Poses a relatively low risk as a new gene introduced will integrate itself into the genome of the patient and
continue functioning without hampering the operations of other genes.

3. www.stratviewresearch.com
Market Insights
3
By Indication Type
• The market is segmented as neurological diseases, cancer, duchenne muscular dystrophy, heptological, and others.
• The cancer segment is expected to experience the highest growth in the market during the forecast period.
• This growth can be attributed to the approval of a growing number of gene therapies for the treatment of cancer and
the rising incidences of hematologic cancers.
By Vector Type
• The market is segmented as non-viral and viral vectors.
• The non-viral vectors’ segment has been further bifurcated into oligonucleotides and others; and the viral vectors’
segment has been further bifurcated into retroviral vectors, adeno-associated virus vectors, and others.
• The non-viral vectors’ segment is expected to grow at a higher rate over the forecast period, owing to the higher
market penetration of oligonucleotide-based non-viral vector gene therapies.
By Region
• In terms of regions, North America is estimated to be the largest market during the forecast period with lucrative
growth opportunities.
• This growth can be attributed to the presence of major players, rising prevalence of chronic diseases, high and
increasing healthcare expenditure, presence of advanced healthcare infrastructure, and availability of
reimbursements.
• Europe and Asia-Pacific are also expected to offer substantial growth opportunities during the forecast period.

4. www.stratviewresearch.com
Competitive Insights
4
Gene Therapy Market, regional expansion, and execution of mergers & acquisitions are the key strategies
adopted by the major players to gain a competitive edge in the market.
Key Companies Analysed
• Biogen, Inc.
• Novartis International AG
• Gilead Sciences, Inc.
• Spark Therapeutics, Inc.
• MolMed S.p.A.
• Orchard Therapeutics plc.
• Sibiono GeneTech Co. Ltd.
• Shanghai Sunway Biotech Co., Ltd.
• Bluebird Bio
• Human Stem Cells Institute PJSC
• AnGes MG, Inc.
• Alnylam Pharmaceuticals, Inc.
• Sarepta Therapeutics, Inc.
• Jazz Pharmaceuticals, Inc.
• Akcea Therapeutics
• Dynavax Technologies Corporation.

5. www.stratviewresearch.com
Research Methodology
5
• Annual Reports / Fact Book
• Company Websites
• Magazines / Publications
• Press Releases & Journals
• Industry News
• Association Articles
• Government Documents
• Social Media
• Others
• Robust database across value chain
• In-house industry veterans as
advisors
• Project based subject matter experts
• Industry Players
• Industry Experts
• Suppliers
• Customers
• Associations
• Government Institutions
• Others
Data Triangulation Data Evaluation and Multiple Data Triangulation)
Final Deliverables Final Report with All Findings)
Secondary Research
Stratview Research Internal
Knowledgebase
Primary Research
Stratview Research follows a rigorous methodology with high emphasis on primary research and multiple ways of
data triangulation. We conduct primary research across the value chain to provide 360 degree view of the market.
Data Analysis Top Down and Bottom Up Approach)

6. www.stratviewresearch.com
Report Features
6
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it
offers maximum business value. It provides critical insights on the market dynamics and will enable strategic decision
making for the existing market players as well as those willing to enter the market. The following are the key features of
the report:
• Market structure: Overview, industry life cycle analysis, supply chain analysis.
• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
• Market trend and forecast analysis.
• Market segment trend and forecast.
• Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
• Attractive market segments and associated growth opportunities.
• Emerging trends.
• Strategic growth opportunities for the existing and new players.
• Key success factors.

7. www.stratviewresearch.com 7
Market Segmentation
The gene therapy market is segmented into the following categories.
Gene Therapy Market Size, Share, & Forecast, by Vector Type:
• Non-Viral Vectors
• (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• (Vector Type Analysis: Oligonucleotides and Other Non-Viral Vectors)
• Viral Vectors
• (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• (Vector Type Analysis: Retroviral Vectors, Adeno-Associated Virus Vectors, and Other Viral Vectors)
Gene Therapy Market Size, Share, & Forecast, by Indication Type:
• Neurological Diseases (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Cancer (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Duchenne Muscular Dystrophy (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Hepatological Diseases (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Others (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

8. www.stratviewresearch.com 8
Market Segmentation
Gene Therapy Market Size, Share, & Forecast, by Delivery Method Type:
• In Vivo Gene Therapy (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
• Ex Vivo Gene Therapy (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
Gene Therapy Market Size, Share, & Forecast, by Region:
• North America (Country Analysis: the USA, Canada, and Mexico)
• Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
• Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
• Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

9. www.stratviewresearch.com
About Stratview Research
9
Stratview Research is a global market intelligence firm providing high quality syndicated reports,
custom research and consulting services.
Market Reports
Advisory & Consulting
Custom Research
Rich Industry Experience
High Customer Delight
Effective Business Decisions
Robust Methodology
Our Services Why Us?

10. www.stratviewresearch.com
Contact Us for More Information and Sample Pages
10
Email us at:
sales@stratviewrsearch.com
Call Us:
+1-313-307-4176
Ask for Sample Pages here:
https://www.stratviewresearch.com/Request-Sample/942/gene-therapy-market.html#form

11. www.stratviewresearch.com 11
Thank You